{"pmid":32405270,"pmcid":"PMC7219422","title":"Detection of SARS-CoV-2 is comparable in clinical samples preserved in saline or viral transport media.","text":["Detection of SARS-CoV-2 is comparable in clinical samples preserved in saline or viral transport media.","As the COVID-19 pandemic sweeps across the world, the availability of viral transport media (VTM) has become severely limited, contributing to delays in diagnosis and rationing of diagnostic testing. Given that SARS-CoV-2 viral RNA has demonstrated stability, we posited that phosphate buffered saline (PBS) may be a viable transport medium, as an alternative to VTM), for clinical qPCR testing. We assessed the intra- and inter-individual reliability of SARS-CoV-2 qPCR in clinical endotracheal secretion samples transported in VTM or PBS, evaluating the stability of the RT-qPCR signal for three viral targets (N gene, ORF1ab, and S gene) when samples were stored in these media at room temperature for up to 18 hours. We report that using PBS as a transport medium has high intra-and inter-individual reliability, maintains viral stability, and is comparable to VTM in the detection of the three SARS-CoV-2 genes through 18 hours of storage. Our study establishes PBS as a clinically useful medium that can be readily deployed for transporting and short-term preservation of specimens containing SARS-CoV-2. Use of PBS as a transport medium has the potential to increase testing capacity for SARS-CoV-2, aiding more widespread screening and early diagnosis of COVID-19.","J Mol Diagn","Radbel, Jared","Jagpal, Sugeet","Roy, Jason","Brooks, Andrew","Tischfield, Jay","Sheldon, Michael","Bixby, Christian","Witt, Dana","Gennaro, Maria Laura","Horton, Daniel B","Barrett, Emily S","Carson, Jeffrey L","Panettieri, Reynold A Jr","Blaser, Martin J","32405270"],"abstract":["As the COVID-19 pandemic sweeps across the world, the availability of viral transport media (VTM) has become severely limited, contributing to delays in diagnosis and rationing of diagnostic testing. Given that SARS-CoV-2 viral RNA has demonstrated stability, we posited that phosphate buffered saline (PBS) may be a viable transport medium, as an alternative to VTM), for clinical qPCR testing. We assessed the intra- and inter-individual reliability of SARS-CoV-2 qPCR in clinical endotracheal secretion samples transported in VTM or PBS, evaluating the stability of the RT-qPCR signal for three viral targets (N gene, ORF1ab, and S gene) when samples were stored in these media at room temperature for up to 18 hours. We report that using PBS as a transport medium has high intra-and inter-individual reliability, maintains viral stability, and is comparable to VTM in the detection of the three SARS-CoV-2 genes through 18 hours of storage. Our study establishes PBS as a clinically useful medium that can be readily deployed for transporting and short-term preservation of specimens containing SARS-CoV-2. Use of PBS as a transport medium has the potential to increase testing capacity for SARS-CoV-2, aiding more widespread screening and early diagnosis of COVID-19."],"journal":"J Mol Diagn","authors":["Radbel, Jared","Jagpal, Sugeet","Roy, Jason","Brooks, Andrew","Tischfield, Jay","Sheldon, Michael","Bixby, Christian","Witt, Dana","Gennaro, Maria Laura","Horton, Daniel B","Barrett, Emily S","Carson, Jeffrey L","Panettieri, Reynold A Jr","Blaser, Martin J"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405270","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jmoldx.2020.04.209","topics":["Diagnosis"],"weight":1,"_version_":1666802845455745024,"score":9.490897,"similar":[{"pmid":32405257,"pmcid":"PMC7219399","title":"Validation of SARS-CoV-2 detection across multiple specimen types.","text":["Validation of SARS-CoV-2 detection across multiple specimen types.","Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused considerable disruption across the world, resulting in more than 235,000 deaths since December 2019. SARS-CoV-2 has a wide tropism and detection of the virus has been described in multiple specimen types, including various respiratory secretions, cerebrospinal fluid, and stool. Objective: To evaluate the accuracy and sensitivity of a laboratory modified CDCbased SARS-CoV-2 N1 and N2 assay across a range of sample types. Study Design We compared the matrix effect on the analytical sensitivity of SARS-CoV-2 detection by qRT-PCR in nasal swabs collected in viral transport medium (VTM), bronchoalveolar lavage (BAL), sputum, plasma, cerebral spinal fluid (CSF), stool, VTM, phosphate buffered saline (PBS), and Hanks' Balanced Salt Solution (HBSS). Initial limits of detection (LoD) were subsequently narrowed to confirm an LoD for each specimen type and target gene. Results: LoDs were established using a modified CDC-based laboratory developed test and ranged from a mean CT cut-off of 33.8-35.7 (10-20 copies/reaction) for the N1 gene target, and 34.0-36.2 (1-10 copies/reaction) for N2. Alternatives to VTM such as PBS and HBSS had comparable LoDs. The N2 gene target was found to be most sensitive in CSF. Conclusion: A modified CDC-based laboratory developed test is able to detect SARSCoV- 2 accurately with similar sensitivity across all sample types tested.","J Clin Virol","Perchetti, Garrett A","Nalla, Arun K","Huang, Meei-Li","Zhu, Haiying","Wei, Yulun","Stensland, Larry","Loprieno, Michelle A","Jerome, Keith R","Greninger, Alexander L","32405257"],"abstract":["Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused considerable disruption across the world, resulting in more than 235,000 deaths since December 2019. SARS-CoV-2 has a wide tropism and detection of the virus has been described in multiple specimen types, including various respiratory secretions, cerebrospinal fluid, and stool. Objective: To evaluate the accuracy and sensitivity of a laboratory modified CDCbased SARS-CoV-2 N1 and N2 assay across a range of sample types. Study Design We compared the matrix effect on the analytical sensitivity of SARS-CoV-2 detection by qRT-PCR in nasal swabs collected in viral transport medium (VTM), bronchoalveolar lavage (BAL), sputum, plasma, cerebral spinal fluid (CSF), stool, VTM, phosphate buffered saline (PBS), and Hanks' Balanced Salt Solution (HBSS). Initial limits of detection (LoD) were subsequently narrowed to confirm an LoD for each specimen type and target gene. Results: LoDs were established using a modified CDC-based laboratory developed test and ranged from a mean CT cut-off of 33.8-35.7 (10-20 copies/reaction) for the N1 gene target, and 34.0-36.2 (1-10 copies/reaction) for N2. Alternatives to VTM such as PBS and HBSS had comparable LoDs. The N2 gene target was found to be most sensitive in CSF. Conclusion: A modified CDC-based laboratory developed test is able to detect SARSCoV- 2 accurately with similar sensitivity across all sample types tested."],"journal":"J Clin Virol","authors":["Perchetti, Garrett A","Nalla, Arun K","Huang, Meei-Li","Zhu, Haiying","Wei, Yulun","Stensland, Larry","Loprieno, Michelle A","Jerome, Keith R","Greninger, Alexander L"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405257","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jcv.2020.104438","keywords":["bal","csf","sars-cov-2","coronavirus","sensitivity","specimen type"],"topics":["Diagnosis"],"weight":1,"_version_":1666802845614080001,"score":763.427},{"pmid":32470887,"title":"Validation of SARS-CoV-2 detection across multiple specimen types.","text":["Validation of SARS-CoV-2 detection across multiple specimen types.","BACKGROUND: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused considerable disruption across the world, resulting in more than 235,000 deaths since December 2019. SARS-CoV-2 has a wide tropism and detection of the virus has been described in multiple specimen types, including various respiratory secretions, cerebrospinal fluid, and stool. OBJECTIVE: To evaluate the accuracy and sensitivity of a laboratory modified CDCbased SARS-CoV-2 N1 and N2 assay across a range of sample types. Study Design We compared the matrix effect on the analytical sensitivity of SARS-CoV-2 detection by qRT-PCR in nasal swabs collected in viral transport medium (VTM), bronchoalveolar lavage (BAL), sputum, plasma, cerebral spinal fluid (CSF), stool, VTM, phosphate buffered saline (PBS), and Hanks' Balanced Salt Solution (HBSS). Initial limits of detection (LoD) were subsequently narrowed to confirm an LoD for each specimen type and target gene. RESULTS: LoDs were established using a modified CDC-based laboratory developed test and ranged from a mean CT cut-off of 33.8-35.7 (10-20 copies/reaction) for the N1 gene target, and 34.0-36.2 (1-10 copies/reaction) for N2. Alternatives to VTM such as PBS and HBSS had comparable LoDs. The N2 gene target was found to be most sensitive in CSF. CONCLUSION: A modified CDC-based laboratory developed test is able to detect SARSCoV- 2 accurately with similar sensitivity across all sample types tested.","J Clin Virol","Perchetti, Garrett A","Nalla, Arun K","Huang, Meei-Li","Zhu, Haiying","Wei, Yulun","Stensland, Larry","Loprieno, Michelle A","Jerome, Keith R","Greninger, Alexander L","32470887"],"abstract":["BACKGROUND: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused considerable disruption across the world, resulting in more than 235,000 deaths since December 2019. SARS-CoV-2 has a wide tropism and detection of the virus has been described in multiple specimen types, including various respiratory secretions, cerebrospinal fluid, and stool. OBJECTIVE: To evaluate the accuracy and sensitivity of a laboratory modified CDCbased SARS-CoV-2 N1 and N2 assay across a range of sample types. Study Design We compared the matrix effect on the analytical sensitivity of SARS-CoV-2 detection by qRT-PCR in nasal swabs collected in viral transport medium (VTM), bronchoalveolar lavage (BAL), sputum, plasma, cerebral spinal fluid (CSF), stool, VTM, phosphate buffered saline (PBS), and Hanks' Balanced Salt Solution (HBSS). Initial limits of detection (LoD) were subsequently narrowed to confirm an LoD for each specimen type and target gene. RESULTS: LoDs were established using a modified CDC-based laboratory developed test and ranged from a mean CT cut-off of 33.8-35.7 (10-20 copies/reaction) for the N1 gene target, and 34.0-36.2 (1-10 copies/reaction) for N2. Alternatives to VTM such as PBS and HBSS had comparable LoDs. The N2 gene target was found to be most sensitive in CSF. CONCLUSION: A modified CDC-based laboratory developed test is able to detect SARSCoV- 2 accurately with similar sensitivity across all sample types tested."],"journal":"J Clin Virol","authors":["Perchetti, Garrett A","Nalla, Arun K","Huang, Meei-Li","Zhu, Haiying","Wei, Yulun","Stensland, Larry","Loprieno, Michelle A","Jerome, Keith R","Greninger, Alexander L"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470887","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jcv.2020.104438","keywords":["bal","csf","coronavirus","sars-cov-2","sensitivity","specimen type"],"topics":["Diagnosis"],"weight":1,"_version_":1668167110070632448,"score":763.427},{"pmid":32404481,"title":"Large-scale, in-house production of viral transport media to support SARS-CoV-2 PCR testing in a multi-hospital healthcare network during the COVID-19 pandemic.","text":["Large-scale, in-house production of viral transport media to support SARS-CoV-2 PCR testing in a multi-hospital healthcare network during the COVID-19 pandemic.","The COVID-19 pandemic has severely disrupted worldwide supplies of viral transport media (VTM) due to widespread demand for SARS-CoV-2 RT-PCR testing. In response to this ongoing shortage, we began production of VTM in-house in support of diagnostic testing in our hospital network. As our diagnostic laboratory was not equipped for reagent production, we took advantage of space and personnel that became available due to closure of the research division of our medical center. We utilized a formulation of VTM described by the CDC that was simple to produce, did not require filtration for sterilization, and used reagents that were available from commercial suppliers. Performance of VTM was evaluated by several quality assurance measures. Based on Ct values of spiking experiments, we found that our VTM supported highly consistent amplification of the SARS-CoV-2 target (coefficient of variation = 2.95%) using the Abbott RealTime SARS-CoV-2 EUA assay on the Abbott m2000 platform. VTM was also found to be compatible with multiple swab types and, based on accelerated stability studies, able to maintain functionality for at least four months at room temperature. We further discuss how we met logistical challenges associated with large-scale VTM production in a crisis setting including use of staged, assembly line for VTM transport tube production.","J Clin Microbiol","Smith, Kenneth P","Cheng, Annie","Chopelas, Amber","DuBois-Coyne, Sarah","Mezghani, Ikram","Rodriguez, Shade","Talay, Mustafa","Kirby, James E","32404481"],"abstract":["The COVID-19 pandemic has severely disrupted worldwide supplies of viral transport media (VTM) due to widespread demand for SARS-CoV-2 RT-PCR testing. In response to this ongoing shortage, we began production of VTM in-house in support of diagnostic testing in our hospital network. As our diagnostic laboratory was not equipped for reagent production, we took advantage of space and personnel that became available due to closure of the research division of our medical center. We utilized a formulation of VTM described by the CDC that was simple to produce, did not require filtration for sterilization, and used reagents that were available from commercial suppliers. Performance of VTM was evaluated by several quality assurance measures. Based on Ct values of spiking experiments, we found that our VTM supported highly consistent amplification of the SARS-CoV-2 target (coefficient of variation = 2.95%) using the Abbott RealTime SARS-CoV-2 EUA assay on the Abbott m2000 platform. VTM was also found to be compatible with multiple swab types and, based on accelerated stability studies, able to maintain functionality for at least four months at room temperature. We further discuss how we met logistical challenges associated with large-scale VTM production in a crisis setting including use of staged, assembly line for VTM transport tube production."],"journal":"J Clin Microbiol","authors":["Smith, Kenneth P","Cheng, Annie","Chopelas, Amber","DuBois-Coyne, Sarah","Mezghani, Ikram","Rodriguez, Shade","Talay, Mustafa","Kirby, James E"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404481","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1128/JCM.00913-20","locations":["Abbott"],"topics":["Diagnosis"],"weight":1,"_version_":1666950579810729985,"score":584.4678},{"pmid":32341141,"title":"Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR.","text":["Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR.","The global COVID-19 pandemic has resulted in a worldwide shortage of viral transport media and raised questions about specimen stability. The objective of this study was to determine the stability of SARS-CoV-2 virus RNA in specimen transport media under various storage conditions. Transport medium tested included: VCM, UTM(R)-RT, ESwab, M4 and saline (0.9% NaCl). Specimen types tested included Nasopharyngeal/Oropharyngeal (NP/OP) swabs in the above transport media, bronchoalveolar lavage (BAL) and Sputum. A high-titer SARS-CoV-2 remnant patient specimen was spiked into pooled SARS-CoV-2 RNA-negative specimen remnants for the various media types. Aliquots of samples were stored at 18 degrees C to 25 degrees C, 2 degrees C to 8 degrees C and -10 degrees C to -30 degrees C and then tested at time points up to 14 days. Specimens consistently yielded amplifiable RNA with mean Ct differences of <3 over the various conditions assayed, thus supporting the use and transport of alternative collection media and specimen types under a variety of temperature storage conditions.","J Clin Microbiol","Rogers, Amy A","Baumann, Russell E","Borillo, Gwynngelle A","Kagan, Ron M","Batterman, Hollis J","Galdzicka, Marzena","Marlowe, Elizabeth M","32341141"],"abstract":["The global COVID-19 pandemic has resulted in a worldwide shortage of viral transport media and raised questions about specimen stability. The objective of this study was to determine the stability of SARS-CoV-2 virus RNA in specimen transport media under various storage conditions. Transport medium tested included: VCM, UTM(R)-RT, ESwab, M4 and saline (0.9% NaCl). Specimen types tested included Nasopharyngeal/Oropharyngeal (NP/OP) swabs in the above transport media, bronchoalveolar lavage (BAL) and Sputum. A high-titer SARS-CoV-2 remnant patient specimen was spiked into pooled SARS-CoV-2 RNA-negative specimen remnants for the various media types. Aliquots of samples were stored at 18 degrees C to 25 degrees C, 2 degrees C to 8 degrees C and -10 degrees C to -30 degrees C and then tested at time points up to 14 days. Specimens consistently yielded amplifiable RNA with mean Ct differences of <3 over the various conditions assayed, thus supporting the use and transport of alternative collection media and specimen types under a variety of temperature storage conditions."],"journal":"J Clin Microbiol","authors":["Rogers, Amy A","Baumann, Russell E","Borillo, Gwynngelle A","Kagan, Ron M","Batterman, Hollis J","Galdzicka, Marzena","Marlowe, Elizabeth M"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341141","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1128/JCM.00708-20","locations":["UTM(R)-RT"],"e_drugs":["Sodium Chloride"],"topics":["Diagnosis"],"weight":1,"_version_":1666138495100387330,"score":583.3036},{"pmid":32492531,"title":"Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.","text":["Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.","OBJECTIVES: The gold-standard COVID-19 diagnosis relies on detecting SARS-CoV-2 using RNA purification and one-step retrotranscription and quantitative PCR (RT-qPCR). Based on the urgent need for high-throughput screening, we tested the performance of three alternative, simple and affordable protocols to rapidly detect SARS-CoV-2, bypassing the long and tedious RNA extraction step and reducing the time to viral detection. METHODS: We evaluated three methods based on direct nasopharyngeal swab viral transmission medium (VTM) heating before the RT-qPCR: a) direct without additives; b) in a formamide-EDTA (FAE) buffer, c) in a RNAsnap(TM) buffer. RESULTS: Although with a delay in cycle threshold compared to the gold-standard, we found consistent results in nasopharyngeal swab samples that were subject to a direct 70 degrees C incubation for 10 min. CONCLUSIONS: Our findings provide valuable options to overcome any supply chain issue and help to increase the throughput of diagnostic tests, thereby complementing standard diagnosis.","Int J Infect Dis","Alcoba-Florez, Julia","Gonzalez-Montelongo, Rafaela","Inigo-Campos, Antonio","de Artola, Diego Garcia-Martinez","Gil-Campesino, Helena","The Microbiology Technical Support Team","Ciuffreda, Laura","Valenzuela-Fernandez, Agustin","Flores, Carlos","32492531"],"abstract":["OBJECTIVES: The gold-standard COVID-19 diagnosis relies on detecting SARS-CoV-2 using RNA purification and one-step retrotranscription and quantitative PCR (RT-qPCR). Based on the urgent need for high-throughput screening, we tested the performance of three alternative, simple and affordable protocols to rapidly detect SARS-CoV-2, bypassing the long and tedious RNA extraction step and reducing the time to viral detection. METHODS: We evaluated three methods based on direct nasopharyngeal swab viral transmission medium (VTM) heating before the RT-qPCR: a) direct without additives; b) in a formamide-EDTA (FAE) buffer, c) in a RNAsnap(TM) buffer. RESULTS: Although with a delay in cycle threshold compared to the gold-standard, we found consistent results in nasopharyngeal swab samples that were subject to a direct 70 degrees C incubation for 10 min. CONCLUSIONS: Our findings provide valuable options to overcome any supply chain issue and help to increase the throughput of diagnostic tests, thereby complementing standard diagnosis."],"journal":"Int J Infect Dis","authors":["Alcoba-Florez, Julia","Gonzalez-Montelongo, Rafaela","Inigo-Campos, Antonio","de Artola, Diego Garcia-Martinez","Gil-Campesino, Helena","The Microbiology Technical Support Team","Ciuffreda, Laura","Valenzuela-Fernandez, Agustin","Flores, Carlos"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492531","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.ijid.2020.05.099","keywords":["covid-19","rna extraction","sars-cov-2","diagnosis","fast protocols","sample treatment"],"topics":["Diagnosis"],"weight":1,"_version_":1668623433626288129,"score":540.31476}]}